Tolcapone is
**Core Concept**
Tolcapone is a potent, reversible inhibitor of catechol-O-methyltransferase (COMT), an enzyme involved in the metabolism of catecholamines such as dopamine, norepinephrine, and epinephrine. This class of drugs is used to enhance the effects of levodopa in the treatment of Parkinson's disease.
**Why the Correct Answer is Right**
Tolcapone works by selectively inhibiting the COMT enzyme, preventing the breakdown of levodopa and increasing its availability in the brain. This results in improved motor function and reduced symptoms of Parkinson's disease. By inhibiting COMT, tolcapone allows more levodopa to cross the blood-brain barrier, where it can be converted to dopamine and exert its therapeutic effects.
**Why Each Wrong Option is Incorrect**
**Option A:** Tolcapone is not a dopamine agonist, which are drugs that directly stimulate dopamine receptors in the brain. While it does increase dopamine levels, it does so indirectly by inhibiting COMT.
**Option B:** Tolcapone is not a monoamine oxidase B (MAO-B) inhibitor, which are drugs that block the action of the enzyme MAO-B and prevent the breakdown of dopamine. Tolcapone's mechanism of action is distinct from MAO-B inhibitors.
**Option C:** Tolcapone is not a direct-acting cholinesterase inhibitor, which are drugs that block the breakdown of acetylcholine in the brain. While it may have some indirect effects on cholinergic systems, its primary mechanism of action is through the inhibition of COMT.
**Clinical Pearl / High-Yield Fact**
Tolcapone is often used in combination with levodopa and carbidopa to enhance its effects and delay the progression of Parkinson's disease. However, it can cause hepatotoxicity and requires regular monitoring of liver enzymes.
**Correct Answer:** C. A COMT inhibitor used in Parkinson's disease